{"title":"Toward once-monthly insulin therapy via synergy in two pharmacokinetic protractors: Fc-conjugation and fatty acid acylation.","link":"http://pubs.rsc.org/en/Content/ArticleLanding/2024/CB/D4CB00078A","date":null,"content":"<div><i><b>RSC Chem. Biol.</b></i>, 2024, Accepted Manuscript<br /><b>DOI</b>: 10.1039/D4CB00078A, Paper</div><div><img alt=\"Open Access\" src=\"http://sod-a.rsc-cdn.org/pubs.rsc-uat.org/content/NewImages/open_access_blue.png\" /> Open Access</div><div><a href=\"http://creativecommons.org/licenses/by/3.0/\" target=\"_blank\"> <img src=\"http://sod-a.rsc-cdn.org/pubs.rsc-uat.org/content/NewImages/CCBY.png\" alt=\"Creative Commons Licence\" /></a>  This article is licensed under a <a href=\"http://creativecommons.org/licenses/by/3.0/\" target=\"_blank\">Creative Commons Attribution 3.0 Unported Licence.</a></div><div>Alexander Zaykov, Vasily M Gelfanov, Tina M Tagmose, Damien Demozey, Valentina Manfè, Rebecca Rohlfs, Marita Rivir, Diego Perez-Tilve, Brian Finan, Richard D DiMarchi<br />Pharmacokinetic properties and duration of therapeutic action of a pharmaceutical agent can be significantly extended through the combination of two distinct strategies aimed at increasing plasma half-life: fatty acid acylation...<br />The content of this RSS Feed (c) The Royal Society of Chemistry</div>","author":"","siteTitle":"RSC - RSC Chem. Biol. latest articles","siteHash":"1843dfbfc0bf39b0fe9743f763f2ba4e6cb90d9c3732ca303b2e6e5daeb3deb0","entryHash":"791cbe7d64f284f6f27608963ee0df97dee000463df19539dd5d615a9074864c","category":"Environment"}